Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine production

Justyna Wojno, John-Paul Jukes, Hemza Ghadbane, Dawn Shepherd, Gurdyal S Besra, Vincenzo Cerundolo, Liam R Cox

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)


Invariant natural killer T (iNKT) cells are restricted by the non-polymorphic MHC class I-like protein, CD1d, and activated following presentation of lipid antigens bound to CD1d molecules. The prototypical iNKT cell agonist is α-galactosyl ceramide (α-GalCer). CD1d-mediated activation of iNKT cells by this molecule results in the rapid secretion of a range of pro-inflammatory (Th1) and regulatory (Th2) cytokines. Polarization of the cytokine response can be achieved by modifying the structure of the glycolipid, which opens up the possibility of using CD1d agonists as therapeutic agents for a range of diseases. Analysis of crystal structures of the T-cell receptor-α-GalCer-CD1d complex led us to postulate that amide isosteres of known CD1d agonists should modulate the cytokine response profile upon iNKT-cell activation. To this end, we describe the synthesis and biological activity of amide analogues of α-GalCer and its non-glycosidic analogue threitol ceramide (ThrCer). All of the analogues were found to stimulate murine and human iNKT cells by CD1d-mediated presentation to varying degrees; however, the thioamide and carbamate analogues of ThrCer were of particular interest in that they elicited a strongly polarized cytokine response (more interferon-gamma (IFN-γ), no interleukin-4 (IL-4)) in mice. While the ThrCer-carbamate analogue was shown to transactivate natural killer (NK) cells, a mechanism that has been used to account for the preferential production of IFN-γ by other CD1d agonists, this pathway does not account for the polarized cytokine response observed for the thioamide analogue.
Original languageEnglish
Pages (from-to)847-855
Number of pages9
JournalACS chemical biology
Issue number5
Publication statusPublished - 18 May 2012


Dive into the research topics of 'Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine production'. Together they form a unique fingerprint.

Cite this